Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: Results of a randomised controlled trial

Pain

Volumn 112, Issue 3, 2004, Pages 299-306

  Berman, Jonathan S ^a   Symonds, Catherine ^b   Birch, Rolfe ^a  

^a ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b Porton Down Science Park   (United Kingdom)

Author keywords

Brachial plexus injury; Cannabis; Chronic pain; Neuropathic

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; ANTICONVULSIVE AGENT; CANNABINOID; CANNABIS; DRONABINOL; GABAPENTIN; GW 1000 02; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PLACEBO; PLANT EXTRACT; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ADULT; ANALGESIA; ANXIETY DISORDER; ARTICLE; AVULSION INJURY; BRACHIAL PLEXUS; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DIZZINESS; DRUG INTOXICATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSGEUSIA; EUPHORIA; FEMALE; HEADACHE; HUMAN; HYPOTHESIS; LETHARGY; MALE; MEASUREMENT; MEDICINAL PLANT; MOOD DISORDER; NAUSEA; NEUROPATHIC PAIN; PARANOIA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP; SOMNOLENCE; STATISTICAL SIGNIFICANCE; SYNCOPE; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BRACHIAL PLEXUS NEUROPATHIES; CANNABIDIOL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PLANT EXTRACTS; RETROSPECTIVE STUDIES; SLEEP; TETRAHYDROCANNABINOL; TIME FACTORS; TREATMENT OUTCOME;

EID: 9244223576     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2004.09.013     Document Type: Article

References (42)

1. L. Arseneault, M. Cannon, R. Poulton, R. Murray, A. Caspi, and T.E. Moffitt Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study Br Med J 325 7374 2002 1212 1213
2. C.H. Ashton Adverse effects of cannabis and cannabinoids Br J Anaesth 83 1999 637 649
3. M.H. Banks Validation of the General Health Questionnaire in a young community sample Psychol Med 13 1983 349 353
4. J.S. Berman, R. Birch, and P. Anand Pain following human brachial plexus injury with spinal cord root avulsion and the effect of surgery Pain 75 1998 199 207
5. D. Bridges, K. Ahmad, and A.S. Rice The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain Br J Pharmacol 133 2001 586 594
6. J. Bruxelle, V. Travers, and J.B. Thiebaut Occurrence and treatment of pain after brachial plexus injury Clin Orthop 1988 87 95
7. F.A. Campbell, M.R. Tramer, D. Carroll, D.J. Reynolds, R.A. Moore, and H.J. McQuay Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review Br Med J 323 2001 13 16
8. J.T. Farrar, J.P. Young Jr, L. LaMoreaux, J.L. Werth, and R.M. Poole Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale Pain 94 2001 149 158
9. N.B. Finnerup, H. Gottrup, and T.S. Jensen Anticonvulsants in central pain Expert Opin Pharmacother 3 2002 1411 1420
10. A. Fox, A. Kesingland, C. Gentry, K. McNair, S. Patel, L. Urban, and I. James The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain Pain 92 2001 91 100
11. G.H. Frazier, and P.G. Skillern Supraclavicular lesions of the brachial plexus not associated with skeletal injuries J Am Med Assoc 57 1911 1957 1963
12. M. Guenot, J. Bullier, J.P. Rospars, P. Lansky, P. Mertens, and M. Sindou Single-unit analysis of the spinal dorsal horn in patients with neuropathic pain J Clin Neurophysiol 20 2003 143 150
13. G.W. Guy, and P.J. Robson A Phase I, open label, four-way crossover study to compare the pharmacokinetic profiles of a single dose of 20 mg of a Cannabis Based Medicine Extract (CBME) administered on 3 Different areas of the buccal mucosa and to investigate the pharmacokinetics of CBME per oral in healthy male and female volunteers (GWPK0112) J Cannabis Ther 3 4 2003 79 120
14. W. Hamann, and P.P. di Vadi Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors Lancet 353 1999 560
15. U. Herzberg, E. Eliav, G.J. Bennett, and I.J. Kopin The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain Neurosci Lett 221 1997 157 160
16. R.A. Hirst, D.G. Lambert, and W.G. Notcutt Pharmacology and potential therapeutic uses of cannabis Br J Anaesth 81 1998 77 84
17. A. Holdcroft, M. Smith, A. Jacklin, H. Hodgson, B. Smith, M. Newton, and F. Evans Pain relief with oral cannabinoids in familial Mediterranean fever Anaesthesia 52 1997 483 486
18. M.P. Jensen, P. Karoly, and S. Braver The measurement of clinical pain intensity: a comparison of six methods Pain 27 1986 117 126
19. M.P. Jensen, P. Karoly, E.F. O'Riordan, F. Bland Jr, and R.S. Burns The subjective experience of acute pain. An assessment of the utility of 10 indices Clin J Pain 5 1989 153 159
20. J.E. Joy, S.J. Watson Jr, and J.A. Benson Jr Marijuana and medicine assessing the science base 1999 National Academy Press Washington, DC p. 266
21. J.D. Loeser, A.A. Ward, and L.E. White Jr Chronic deafferentation of human spinal cord neurons J Neurosurg 29 1968 48
22. M.E. Lynch, and A.J. Clark Cannabis reduces opioid dose in the treatment of chronic non-cancer pain J Pain Symptom Manage 25 2003 496 498
23. J. Mao, D.D. Price, J. Lu, L. Keniston, and D.J. Mayer Two distinctive antinociceptive systems in rats with pathological pain Neurosci Lett 280 2000 13 16
24. M. Maurer, V. Henn, A. Dittrich, and A. Hofmann Delta-9- tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial Eur Arch Psychiatry Clin Neurosci 240 1990 1 4
25. J.M. McPartland, and E.B. Russo Cannabis and cannabis extracts: greater than the sum of their parts? J Cannabis Ther 3-4 2001 103 132
26. R. Melzack The short-form McGill Pain Questionnaire Pain 30 1987 191 197
27. D. Moher, K.F. Schulz, and D.G. Altman The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials Lancet 357 2001 1191 1194
28. R.A. Moore, D. Gavaghan, M.R. Tramer, S.L. Collins, and H.J. McQuay Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects Pain 78 1998 209 216
29. B.S. Nashold Jr, and R.H. Ostdahl Dorsal root entry zone lesions for pain relief J Neurosurg 51 1979 59 69
30. W. Notcutt, M. Price, R. Miller, S. Newport, C. Phillips, S. Simmons, and C. Sansom Initial experiences with medicinal cannabis extracts of cannabis for chronic pain: results from 34 'N of 1' studies Anaesthesia 59 2004 440 452
31. J. Ovelmen-Levitt Abnormal physiology of the dorsal horn as related to the deafferentation syndrome Appl Neurophysiol 51 1988 104 116
32. C.B. Parry Pain in avulsion lesions of the brachial plexus Pain 9 1980 41 53
33. G.C. Patton, C. Coffey, J.B. Carlin, L. Degenhardt, M. Lynskey, and W. Hall Cannabis use and mental health in young people: cohort study Br Med J 325 7374 2002 1195 1198
34. R.G. Pertwee Cannabinoid receptors and pain Prog Neurobiol 63 2001 569 611
35. A.S. Rice Cannabinoids and pain Curr Opin Investig Drugs 2 2001 399 414
36. M. Samii, S. Bear-Henney, W. Ludemann, M. Tatagiba, and U. Blomer Treatment of refractory pain after brachial plexus avulsion with dorsal root entry zone lesions Neurosurgery 48 2001 1269 1277 discussion 1275-7
37. R.C. Tait, C.A. Pollard, R.B. Margolis, P.N. Duckro, and S.J. Krause The Pain Disability Index: psychometric and validity data Arch Phys Med Rehabil 68 1987 438 441
38. D.G. Thomas, and N.D. Kitchen Long-term follow up of dorsal root entry zone lesions in brachial plexus avulsion J Neurol Neurosurg Psychiatry 57 1994 737 738
39. D.T. Wade, P. Robson, H. House, P. Makela, and J. Aram A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms Clin Rehabil 17 2003 21 29
40. S.D. Walter Number needed to treat (NNT): estimation of a measure of clinical benefit Stat Med 20 2001 3947 3962
41. J. Zajicek, P. Fox, H. Sanders, D. Wright, J. Vickery, A. Nunn, and A. Thompson Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial Lancet 362 2003 1517 1526
42. S. Zammit, P. Allebeck, S. Andreasson, I. Lundberg, and G. Lewis Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study Br Med J 325 7374 2002 1199